Search results
Small Cell Lung Cancer: Contending With the Facts
Verywell Health via Yahoo News· 10 months agoSmall cell lung cancer (SCLC) is an aggressive form of cancer that is found in 15% of people with lung cancer. The other 85% of people have non-small...
First-Line Treatment for Lung Cancer
Verywell Health via Yahoo News· 2 years agoWhen you are diagnosed with lung cancer, the preferred initial treatment is called the first-line treatment. It may also be referred to as induction...
Advanced Lung Cancer and Immunotherapy
Verywell Health via Yahoo News· 8 months agoImmunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer....
Roche's (RHHBY) Tecentriq Subcutaneous Gets Approval in the EU
Zacks via Yahoo Finance· 4 months agoRoche RHHBY announced that the European Commission has granted marketing authorization to...
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating...
Roche (RHHBY) Tecentriq SC Receives Positive CHMP Opinion
Zacks via Yahoo Finance· 6 months agoRoche RHHBY announced that the European Medicines Agency’s Committee for Medicinal Products for...
Exelixis' Cabometyx/Tecentriq Combo Misses Overall Survival Goal In Lung Cancer Setting
Benzinga via Yahoo Finance· 1 year agoExelixis Inc (NASDAQ: EXEL) announced that the CONTACT-01 study did not meet its primary endpoint of...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
FDA approves Amgen drug for tough-to-treat form of lung cancer
BioPharma Dive via Yahoo Finance· 1 week agoImdelltra, a bispecific antibody targeting a protein called DLL3, is cleared for use following...
Genprex dosing subjects in trial of combination therapy for small-cell lung cancer
Clinical Trials Arena via Yahoo Finance· 2 weeks agoUS-based gene therapy company Genprex has enrolled and dosed the first subject in a Phase I/II trial...